RYOIX Mutual Fund

RYOIX Mutual Fund (Rydex Biotechnology Fund Investor Class) is managed by Rydex Funds with $108.6M in net assets. RYOIX expense ratio is 1.38%, holding 69 positions across sectors including Health Care. Inception date: 1998-04-01.

RYOIX performance shows a YTD return of 26.43%. The 1-year return is 54.25% and the 5-year return is 6.91%. RYOIX dividend yield stands at 9.90%, paid annually.

RYOIX top holdings include Abbvie Inc. (8.5%), Amgen Inc. (5.6%), Gilead Sciences (4.8%), Nvaesrtex Pharmaceuticals Inc (4.3%), Regeneron Pharmaceuticals, Inc. (3.7%). Go to all RYOIX holdings, RYOIX sectors, or RYOIX dividends.

RYOIX can be compared against other funds. Use RYOIX overlap to find shared positions, or RYOIX vs another fund for a side-by-side view. RYOIX alternatives are available via the screener, along with tax-loss harvesting opportunities.